Sales Cycle Length Benchmarks by Industry and 2026-2028 Projections

Sales cycle length is the single most predictive metric for how a B2B pipeline will actually perform in the next four quarters, and most teams are still modeling against pre-pandemic numbers. Cycles have stretched 37% since 2019, buying committees have doubled in a decade, and the median enterprise deal now sits in the pipeline for 90 to 180 days before closing. This guide pulls the 2025 benchmarks by industry and deal size, then projects where cycles are heading through 2028 based on AI adoption curves and committee saturation patterns.

Key takeaways from this report:

• Average B2B sales cycle hit 6.7 months in 2025, up from 4.9 months in 2019, a 37% expansion driven primarily by committee growth and procurement friction.
• Industry matters more than most teams admit: Real Estate & Construction deals average 147 days while SaaS deals close in 67. That is a 2.2x spread on the same “B2B” label.
• Buying committees doubled from 5.4 stakeholders in 2015 to roughly 11 in 2025 and are projected to plateau near 12 by 2028 as dysfunction becomes the binding constraint.
• Enterprise deals take 4.9x longer than SMB deals, averaging 135 days against 22 days. Deal size explains only about 27% of cycle variance though, process and data quality explain the rest.
• AI adoption in sales reached 88% in 2025, but only 20% cycle reduction has been captured. The gap between deployment and outcome is the highest-leverage opportunity for the next two years.
• 2026 should be the first year cycles contract, projected to drop from 6.7 to 6.5 months as AI qualification and proposal automation move from pilot to production at scale.

Why have B2B sales cycles stretched so far over the last six years?

The trend is clear and the explanation is structural. Cycles grew from 4.9 months in 2019 to a 2025 peak of 6.7 months, with the steepest jump occurring between 2021 and 2023 when post-pandemic budget scrutiny collided with rapidly expanding buying groups. Ebsta data shows cycles were 16% longer in H1 2023 than the prior year and 38% longer than 2021. This was not a market blip. It was a regime change.

Three forces account for almost all of the expansion. The first is committee growth, which we cover in its own section below. The second is procurement maturation: SOC 2, GDPR, and vendor risk assessments are now standard even for mid-market purchases, adding two to four weeks to the average cycle. The third is the rise of self-directed buying. Gartner research shows buyers complete roughly 80% of their evaluation before contacting a vendor, which means the time we used to spend nurturing now happens outside our visibility, then resurfaces as a compressed evaluation window with five vendors already on the shortlist.

The teams that still plan around 2021 cycle times are forecasting with bad assumptions, and bad assumptions are why 87% of enterprises missed their sales forecasts in 2025. If your CRM dashboard says deals should close in 90 days and your reality is 140, that 50-day gap compounds across every quarter and every rep. Re-baseline first, then optimize.
– Emulent Strategy Team

Knowing the trend at the aggregate level is useful for forecasting headcount and pipeline coverage, but it hides the variation that actually shapes go-to-market decisions. Industry context changes the math considerably.

What does “average” really mean across industries?

The headline number for 2025 sits at 84 to 102 days depending on the source. Geckoboard puts the global B2B median at 102 days, Optifai’s larger SaaS-weighted dataset lands at 84. Neither number describes the deal in front of you because the spread by industry is enormous.

How regulated industries set the ceiling on cycle length:

• Real Estate & Construction (147 days): Capital-intensive purchases tied to project milestones, retainage, and multi-tier approvals push timelines past four months as standard practice. Any team selling to this sector that benchmarks against the global B2B median is setting itself up to look broken when it is actually performing on-pace. The fix is to build your forecasting model around construction-industry-specific cycle assumptions.
• Pharmaceuticals (138 days) and Healthcare Enterprise (125 days): Clinical validation, HIPAA, and procurement layers add 60 to 90 days that no SaaS playbook can shortcut. Marketing teams selling into these verticals need pharma-specific content strategy that addresses compliance reviewers as a named audience, not an afterthought.
• Manufacturing (124 days): Equipment integration, multi-stakeholder approvals, and capex sign-off make this a high-cycle, high-value category. The compensation is deal size; Manufacturing averages $47,800 per close.
• Financial Services (89 days): Regulated but more software-comparable than pharma. Cycles run mid-range with strong deal sizes around $31,200.
• SaaS (67 days), Retail (70 days), Healthcare General (72 days): Lower-friction procurement, subscription-based commitment, and faster decision authority compress these to the bottom of the range. SaaS leads because the buyer can cancel next month, which lowers the perceived risk of a wrong choice.

The takeaway is not that some industries are slow and some are fast. It is that “B2B average” is a misleading category when the realistic floor and ceiling differ by 80 days. A construction equipment dealer comparing itself to a SaaS-weighted benchmark will conclude its team is failing when it is actually meeting industry norms.

Why is the buying committee the biggest variable in cycle length?

If only one variable could be tracked to predict cycle compression or expansion, it would be the size of the buying committee. The number of stakeholders involved in a typical B2B purchase has roughly doubled in ten years, and every additional stakeholder adds research time, coordination time, and a new opportunity for the deal to stall.

The data points come from credible primary sources. CEB/Gartner’s 2015 Challenger Customer research established the 5.4-person baseline. Gartner’s 2020 update moved that to 6.8. By 2025, 6sense’s Buyer Experience Report had the core decision group at roughly 10 to 11, and Forrester’s State of Business Buying counted 13 internal stakeholders plus 9 external influencers for a total of 22 people touching the typical decision.

What changes when committees keep expanding:

• Internal consensus becomes the gating step, not vendor evaluation: Gartner reports that 80% of B2B deals fail because of internal consensus failures, not because the vendor lost the bake-off. The work the buying group does to align with itself now consumes more time than the work they do evaluating you.
• Conflict scales faster than coordination: Gartner’s 2025 survey found that 74% of buyer teams display unhealthy conflict during the decision process. Adding a tenth stakeholder does not improve the decision, it adds another vector of disagreement.
• Multi-threading is no longer optional: Engaging only a champion in a 10-person committee gives you roughly 10% influence over the outcome. Deals where reps engage three or more stakeholders by stage two close 35% faster on average.

We project committee size plateaus near 12 by 2028 not because organizations want smaller groups, but because larger groups stop functioning. Once a buying team passes roughly 13 people, decisions slow to the point where the project itself stalls. That natural ceiling is the only force pulling cycle length back down without AI intervention.
– Emulent Strategy Team

Committee size explains why an enterprise deal is structurally different from a small business deal, not just a bigger version of one. That structural difference shows up clearly when we segment by deal value.

How does deal size compound cycle length?

A 10-person company has a founder who can say yes and swipe a card. A 10,000-person company has IT, finance, legal, procurement, security, and three business unit heads who must each sign off. The cycle difference is not linear, it is compounding.

SMB deals under $15K ACV close in 14 to 30 days on average, with the dataset median around 22 days. Mid-market deals between $15K and $100K average 60 days. Enterprise deals over $100K cluster around 135 days, with deals above $250K regularly extending to 9 to 18 months. The 4.9x multiplier between SMB and enterprise is consistent across multiple benchmark datasets.

Worth noting: HockeyStack’s regression analysis across 54 B2B SaaS companies found deal size explains only about 27% of cycle variance. The other 73% is process maturity, buyer intent, and data quality. Teams that blame long cycles entirely on “we sell enterprise deals” are usually wrong about what is actually slowing them down. The customer acquisition cost economics for each tier also shift considerably, which matters when modeling pipeline coverage.

Where is AI actually shortening the cycle, and where is it just being talked about?

AI adoption in sales reached 88% in 2025 per McKinsey, but measured cycle reduction has only reached 20% for the adopting teams. The gap is large and it is the single highest-leverage area for sales leaders to focus on through 2026.

Where AI is producing measured cycle compression today:

• Lead qualification (15-20% reduction): AI-driven scoring routes the right leads to the right reps faster, which front-loads the cycle. Salesforce reports 69% of sellers using AI shortened cycles by approximately one week, mostly through better qualification.
• Proposal turnaround (25-35% reduction at stage 4): Deals where proposals are sent within 24 hours of demo close 35% faster than those where proposals take three to five days. Pre-built proposal templates with AI fill-in is the operational change behind this number.
• Follow-up automation (10-15% reduction): The Salesforce data showing 70% of B2B deals die within 48 hours of demo points to follow-up timing as a major leak. Behavior-triggered nudges reduce the dropout rate at this stage materially.
• Demo personalization (15-17% reduction in enterprise): Pre-recorded demos with AI personalization and pricing calculators cut enterprise cycle times 17% without reducing ACV. The 1-week delay for “let me build you a custom demo” disappears.

AI adoption is not deployment. The 88% adoption number includes any team using any AI tool for any sales function, which is mostly content generation for outreach. The 20% cycle reduction is what teams actually capture when they integrate AI into qualification, proposals, and follow-up as a system. Most of our clients are at adoption stage and have not yet captured the cycle compression. That is the work for 2026.
– Emulent Strategy Team

The forecast through 2028 assumes adoption saturates near 97% as laggards are pulled along, and cycle reduction lags adoption by 12 to 18 months as teams move from pilot to production. Cycle reduction plateaus near 30% because once buying friction (committee size, procurement, security review) dominates the timeline, AI cannot compress what is fundamentally a human consensus problem.

What should sales leaders model into 2028?

The most useful forecasting move for the next two years is to stop using a single blended average and start modeling cycles by segment with explicit assumptions about AI deployment. The bands below give a starting point.

Cycle length assumptions to model for 2026 through 2028:

• SMB (under $15K ACV): Hold at 18 to 22 days. AI compression has the smallest absolute effect here because cycles are already short and the buying committee is typically one or two people.
• Mid-Market ($15K to $100K ACV): Model 48 to 55 days by 2028, down from 60. The largest absolute gains come from this segment because the committee is large enough that proposal automation and qualification AI have material impact.
• Enterprise (over $100K ACV): Model 110 to 125 days by 2028, down from 135. Most of the compression comes from collapsing the proposal and demo stages. The discovery and approval stages remain stubbornly long because they are bound by committee dynamics and procurement.
• Regulated industries (Pharma, Healthcare Enterprise, Construction): Model 110 to 135 days even with full AI deployment. Compliance reviews are not AI-compressible. Plan for it and price for it.

Two strategic implications follow from this. First, pipeline coverage ratios need recalibration. A team running on 3x pipeline coverage with a 90-day model is actually carrying 4.5x coverage on a 135-day reality, which inflates marketing spend and creates false confidence in the forecast. Second, the SDR-to-AE ratio and the marketing-to-sales handoff timing need to reflect the actual cycle length of your largest deal segment, not the blended average. Teams selling enterprise deals on an SMB-tuned cadence burn out their reps trying to push deals that are structurally going to take five months.

The teams pulling ahead in 2026 are not the ones with the most AI tools. They are the ones who took their actual 2025 cycle data, segmented it by tier and industry, modeled the AI compression they can realistically capture given their team’s deployment maturity, and rebuilt their pipeline coverage assumptions from the ground up. That is unglamorous work and it is the only work that materially changes a forecast.
– Emulent Strategy Team

For teams operating in saturated or competitive verticals, cycle compression should be paired with sharper positioning. Even a 20% cycle reduction loses its value if every shortlist has six vendors that look identical. The compression buys you time but you still need a defensible position to close into.

Where the Emulent team can help

The 2026 to 2028 window is when the gap between teams that compressed their cycles and teams that did not becomes a competitive moat. The work is unglamorous: segmented benchmarking, AI deployment into qualification and proposal workflows, content built specifically for committee dynamics rather than generic buyer personas, and pipeline coverage models that reflect actual cycle reality. We help B2B marketing and revenue teams do that work end to end, from the diagnostic against your real cycle data to the operational build-out of the systems that compress it.

If your forecast assumptions feel disconnected from what your reps are actually seeing in the field, or if your pipeline coverage math has stopped working, our team can help you re-baseline. Contact the Emulent team for a free B2B marketing strategy consultation and we will walk through your cycle data with you and identify the two or three changes most likely to move the number this quarter.